Our Company / Alfasigma at glance
Pharmaceuticals
with passion
Alfasigma is a global pharmaceutical company founded over 75 years ago in Italy, where it is headquartered (in Bologna and Milan).
The Group operates in over 100 markets spanning Europe, North and South America, Asia, and Africa. It has offices in many countries, including Italy, the US, Spain, Germany, Mexico, and China; production sites in Italy (Pomezia, RM; Alanno, PE; Sermoneta, LT; Trezzano Rosa, MI), Spain (Tortosa, Baix Ebre), and the United States (Shreveport, Louisiana); and R&D labs in Italy (Pomezia and Bergamo).
Alfasigma employs approximately 4,000 people dedicated to research, development, production, and distribution of medicinal products, contributing to its mission to provide better health and a better quality of life for patients, caregivers, and healthcare providers.
It focuses on three main therapeutic areas: Gastroenterology, Vascular, and Rheumatology. Its portfolio spans from primary care to specialty care, rare disease medications, and consumer health products, including medical foods and nutraceuticals.
Geographic coverage
Subsidiaries
24 countries
Direct subsidiaries
Turnover
1.87 €
Billions in 2024
% Revenue Growth 2024
year-on-year
Driven by:
1. Solid organic growth driven by key strategic legacy brands
2. Successful integration
of recent acquisitions
Morpho - Alfasigma's CDMO Business Unit
Morpho is a distinctive Contract Development and Manufacturing Organisation (CDMO), providing end-to-end pharmaceutical and nutraceutical solutions tailored to our partners' needs worldwide.
By combining technical excellence with a customer-centric approach, Morpho is dedicated to meeting the specific needs of its partners while shaping the future of pharmaceutical manufacturing.
2
R&D Lab centers
6
Manufacturing plants
24
Countries with direct subsidiaries worldwide
Read More
Our culture is based on four core Beliefs which are at the heart of who we are and how we operate.